BioCentury
ARTICLE | Company News

Metra deal

July 5, 1994 7:00 AM UTC

Orquest received $4.4 million in its initial round of financing from Asset Management, Institutional Venture Partners and the Mayfield Fund. Orquest has exclusive worldwide rights to Ultrafiber techno...